Yorktown Management & Research Company’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

Yorktown Management & Research Company’s Portfolio SCLN Stock Details SCLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-37,800	Closed	-$423K	–	434
2017 Q3	$423K	Buy	+37,800	New	+$417K	0.11%	121

Yorktown Management & Research Company's SCLN Position: Q4 2017 in Review

Yorktown Management & Research Company sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q4 2017, closing a stake of 37,800 shares — an estimated $423K sold.

Yorktown Management & Research Company first reported a position in SCLN in Q3 2017 and held it in 1 quarter. The position peaked at $423K in Q3 2017. 0 funds tracked by Wall St. Rank hold SCLN as of Q4 2017.

Yorktown Management & Research Company reported no remaining Sciclone Pharmaceuticals Inc position as of Q4 2017 after selling out during the quarter.
Yorktown Management & Research Company sold 37,800 Sciclone Pharmaceuticals Inc shares in Q4 2017, an estimated $423K.
Yorktown Management & Research Company first reported a position in Sciclone Pharmaceuticals Inc in Q3 2017 and held it in 1 quarter.
Yorktown Management & Research Company's Sciclone Pharmaceuticals Inc position peaked at $423K in Q3 2017.
0 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q4 2017.

Based on Yorktown Management & Research Company's 13F filing for Q4 2017, filed 13 Feb 2018.